RVW Wealth’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

RVW Wealth’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-271	Closed	-$2.2K	–	161
2023 Q1	$2.2K	Hold	271	–	–	﹤0.01%	155
2022 Q4	$3.22K	Buy	+271	New	+$3.1K	﹤0.01%	150
2022 Q3	–	Sell	-271	Closed	-$10K	–	134
2022 Q2	$10K	Hold	271	–	–	﹤0.01%	126
2022 Q1	$11K	Hold	271	–	–	﹤0.01%	136
2021 Q4	$11K	Hold	271	–	–	﹤0.01%	136
2021 Q3	$0	Hold	271	–	–	﹤0.01%	123
2021 Q2	$0	Hold	271	–	–	﹤0.01%	110
2021 Q1	$1M	Hold	271	–	–	0.13%	103
2020 Q4	$1M	Hold	271	–	–	0.15%	95
2020 Q3	$15K	Hold	271	–	–	﹤0.01%	96
2020 Q2	$10K	Hold	271	–	–	﹤0.01%	93
2020 Q1	$7K	Buy	+271	New	+$11.5K	﹤0.01%	92

Other funds holding DMK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

RVW Wealth's DMK Position: Q2 2023 in Review

RVW Wealth sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 271 shares — an estimated $2.2K sold.

RVW Wealth first reported a position in DMK in Q1 2020 and held it in 12 quarters. The position peaked at $1M in Q1 2021. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

RVW Wealth reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
RVW Wealth sold 271 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $2.2K.
RVW Wealth first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2020 and held it in 12 quarters.
RVW Wealth's DMK Pharmaceuticals Corporation Common Stock position peaked at $1M in Q1 2021.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on RVW Wealth's 13F filing for Q2 2023, filed 7 Jul 2023.